• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绘制纳米药物递送系统治疗泌尿系统癌症的全球研究格局和趋势图:文献计量分析。

Mapping global research landscape and trend of nano-drug delivery system for urological cancers: a bibliometric analysis.

机构信息

Institute of Urology, Lanzhou University Second Hospital, Key Laboratory of Gansu Province for Urological Diseases, Gansu Nephro-Urological Clinical Center, Lanzhou, China.

Clinical School of Cardiovascular Disease, Tianjin Medical University, Tianjin, China.

出版信息

Nanomedicine (Lond). 2024;19(26):2139-2157. doi: 10.1080/17435889.2024.2391267. Epub 2024 Sep 3.

DOI:10.1080/17435889.2024.2391267
PMID:39225560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11485865/
Abstract

We conducted a bibliometric analysis to quantitatively study the development pathway, research hotspots and evolutionary trends of nano-drug delivery systems (NDDS) in treating urological tumors. We used the Web of Science Core Collection to retrieve the literature related to NDDS in the urological tumors up to November 1, 2023. Bibliometric analysis and visualization were conducted using CiteSpace, VOSviewer and R-Bibliometrix. The major aspects of analysis included contributions from different countries/regions, authors' contributions, keywords identification, citation frequencies and overall research trends. We included 3,220 articles. The analysis of annual publication trends revealed significant growth in this field since 2010, which has continued to the present day. The United States and China have far exceeded other countries/regions in the publication volume of papers in this field. The progression of the shell structure of NDDS in the urinary system has gradually transitioned from non-biological materials to biocompatible materials and ultimately to completely biocompatible materials. Mucoadhesive NDDS for intravesical drug delivery is a hotspot and a potential research material for bladder cancer. The field of NDDS in urological tumors has emerged as a research hotspot. Future research should focus on synergistic effects of NDDS with other treatment modalities.

摘要

我们进行了文献计量分析,以定量研究纳米药物递送系统(NDDS)在治疗泌尿系统肿瘤方面的发展途径、研究热点和演变趋势。我们使用 Web of Science 核心合集,检索了截至 2023 年 11 月 1 日与泌尿系统肿瘤中 NDDS 相关的文献。使用 CiteSpace、VOSviewer 和 R-Bibliometrix 进行文献计量分析和可视化。分析的主要方面包括不同国家/地区的贡献、作者的贡献、关键词识别、引用频率和整体研究趋势。我们共纳入了 3220 篇文章。年度发表趋势分析显示,自 2010 年以来,该领域的研究呈显著增长趋势,一直持续到今天。美国和中国在该领域的论文发表量远远超过其他国家/地区。NDDS 在泌尿系统中的壳结构的发展逐渐从非生物材料过渡到生物相容性材料,最终完全是生物相容性材料。用于膀胱内药物递送的黏附性 NDDS 是一个热点,也是膀胱癌的潜在研究材料。NDDS 在泌尿系统肿瘤中的研究领域已经成为一个研究热点。未来的研究应集中在 NDDS 与其他治疗方式的协同效应上。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/f03ea76a6092/INNM_A_2391267_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/336f6c41e081/INNM_A_2391267_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/fb03153f6eea/INNM_A_2391267_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/b6f630f9a7b8/INNM_A_2391267_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/f7d7bfc241a2/INNM_A_2391267_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/f03ea76a6092/INNM_A_2391267_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/336f6c41e081/INNM_A_2391267_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/fb03153f6eea/INNM_A_2391267_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/b6f630f9a7b8/INNM_A_2391267_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/f7d7bfc241a2/INNM_A_2391267_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfcf/11485865/f03ea76a6092/INNM_A_2391267_F0005_C.jpg

相似文献

1
Mapping global research landscape and trend of nano-drug delivery system for urological cancers: a bibliometric analysis.绘制纳米药物递送系统治疗泌尿系统癌症的全球研究格局和趋势图:文献计量分析。
Nanomedicine (Lond). 2024;19(26):2139-2157. doi: 10.1080/17435889.2024.2391267. Epub 2024 Sep 3.
2
Nano-drug delivery system for pancreatic cancer: A visualization and bibliometric analysis.胰腺癌的纳米药物递送系统:可视化与文献计量分析
Front Pharmacol. 2022 Oct 18;13:1025618. doi: 10.3389/fphar.2022.1025618. eCollection 2022.
3
Bibliometric and visualized analysis of cancer nanomedicine from 2013 to 2023.2013 年至 2023 年癌症纳米医学的文献计量学和可视化分析。
Drug Deliv Transl Res. 2024 Jun;14(6):1708-1724. doi: 10.1007/s13346-023-01485-7. Epub 2023 Dec 31.
4
Mapping the intellectual structure and landscape of nano-drug delivery systems in colorectal cancer.绘制结直肠癌纳米药物递送系统的知识结构与概况
Front Pharmacol. 2023 Sep 14;14:1258937. doi: 10.3389/fphar.2023.1258937. eCollection 2023.
5
Knowledge mapping of nano drug delivery systems across blood - Brain barrier from 1996 to 2022: A bibliometric analysis.1996年至2022年纳米药物递送系统跨越血脑屏障的知识图谱:一项文献计量分析
Heliyon. 2023 Apr 26;9(5):e15828. doi: 10.1016/j.heliyon.2023.e15828. eCollection 2023 May.
6
Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.溶瘤病毒治疗中枢神经系统肿瘤的研究热点和趋势:文献计量学研究。
Front Immunol. 2022 Sep 6;13:975695. doi: 10.3389/fimmu.2022.975695. eCollection 2022.
7
Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review.乳腺癌纳米颗粒药物递送系统的当前观点与趋势:文献计量分析与综述
Front Bioeng Biotechnol. 2023 Sep 12;11:1253048. doi: 10.3389/fbioe.2023.1253048. eCollection 2023.
8
Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020.2001 年至 2020 年眼部药物输送的文献计量和可视化分析。
J Control Release. 2022 May;345:625-645. doi: 10.1016/j.jconrel.2022.03.031. Epub 2022 Mar 20.
9
Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.人工智能在肿瘤学应用中的研究趋势:文献计量学和网络可视化研究。
Front Biosci (Landmark Ed). 2022 Aug 31;27(9):254. doi: 10.31083/j.fbl2709254.
10
A bibliometric analysis of research on PD-1/PD-L1 in urinary tract tumors.PD-1/PD-L1 在尿路肿瘤研究中的文献计量分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2390727. doi: 10.1080/21645515.2024.2390727. Epub 2024 Oct 10.

本文引用的文献

1
Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy.经氟代聚赖氨酸纳米粒经黏膜递送 CRISPR-Cas9 系统靶向 DAD1 基因治疗膀胱癌的膀胱内基因治疗。
Theranostics. 2024 Jan 1;14(1):203-219. doi: 10.7150/thno.88550. eCollection 2024.
2
Design and Synthesis of Cabazitaxel Loaded Core-Shell Mesoporous Silica Nanoparticles with Different Morphologies for Prostate Cancer Therapy.载多西他赛核壳介孔硅纳米粒的设计与合成及其在前列腺癌治疗中的应用
Small. 2024 Sep;20(39):e2303269. doi: 10.1002/smll.202303269. Epub 2023 Jun 29.
3
Biogenesis of Mesoporous Silica Nanoparticles Enclosed in Extracellular Vesicles by Mouse Renal Adenocarcinoma Cells.
小鼠肾腺癌细胞内囊泡包裹的介孔硅纳米粒子的生物发生。
Methods Mol Biol. 2023;2668:241-256. doi: 10.1007/978-1-0716-3203-1_17.
4
Erratum: T-T Molecular Magnetic Resonance Imaging of Renal Carcinoma Cells Based on Nano-Contrast Agents [Erratum].勘误:基于纳米造影剂的肾癌细胞T-T分子磁共振成像[勘误]
Int J Nanomedicine. 2023 Feb 1;18:561-562. doi: 10.2147/IJN.S404128. eCollection 2023.
5
Thiolated Mesoporous Silica Nanoparticles as an Immunoadjuvant to Enhance Efficacy of Intravesical Chemotherapy for Bladder Cancer.巯基化介孔硅纳米颗粒作为免疫佐剂增强膀胱癌膀胱内化疗的疗效。
Adv Sci (Weinh). 2023 Mar;10(7):e2204643. doi: 10.1002/advs.202204643. Epub 2023 Jan 13.
6
Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis.纳米医学在癌症治疗中的当前观点与趋势:综述与文献计量分析
J Control Release. 2022 Dec;352:211-241. doi: 10.1016/j.jconrel.2022.10.023. Epub 2022 Oct 21.
7
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors.《2022 年世界卫生组织泌尿系统及男性生殖器官肿瘤分类-第 B 部分:前列腺和泌尿系统肿瘤》。
Eur Urol. 2022 Nov;82(5):469-482. doi: 10.1016/j.eururo.2022.07.002. Epub 2022 Aug 11.
8
Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer.光疗联合膀胱癌特异性纳米卟啉增强免疫治疗。
Clin Cancer Res. 2022 Nov 1;28(21):4820-4831. doi: 10.1158/1078-0432.CCR-22-1362.
9
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.2022 年世界卫生组织泌尿系统和男性生殖器官肿瘤分类 - 第 A 部分:肾脏、阴茎和睾丸肿瘤。
Eur Urol. 2022 Nov;82(5):458-468. doi: 10.1016/j.eururo.2022.06.016. Epub 2022 Jul 16.
10
Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy.膀胱癌膀胱内化疗中纳米药物递送系统的当前研究
Front Oncol. 2022 May 24;12:879828. doi: 10.3389/fonc.2022.879828. eCollection 2022.